Edward Drasby

Haplotypes and gene expression implicate the MAPT region for Parkinson disease

H. Shill, J. Growdon, S. Sherman, 2008, Neurology.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Stephanie D. Wilson, S. Ellias, J. Nutt, 2014, JAMA neurology.

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

H. Shill, J. Growdon, S. Sherman, 2008, BMC medicine.